evoke pharma stock target

In 2021 Evoke Pharmas revenue was 162 million an increase of 692900 compared to the previous years 23020. The lowest target is 3636 and the highest is 126.

Evoke Pharma Stock Forecast Up To 3 031 Usd Evok Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis

Evoke Pharma Inc NASDAQ Price.

. Major IndustryPeer Comparison as of 08122022. Complete Evoke Pharma Inc. The most positive votes were given for criterium Worthwhile Investment for the next years.

Evoke Pharma Incs average analyst price target is higher than 1754 of all US stocks. Evoke Pharma Inc. At the mid-range price of 13 a share the IPO would give Evoke Pharma an initial market valuation of roughly 75 million.

With a target price of 12000 there is potential for a 3900000 increase which would mean more than doubling the current price of 300 for Evoke Pharma Inc. Trades from 1. Stock Price Forecast The 1 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 700 with a high estimate of 700 and a low estimate of 700.

On the other hand Evoke Pharmas target price is what analysts think the stock is worth or could sell for in the future. The Wall Street analyst predicted. Dow Jones a News Corp company About WSJ.

The average Evoke Pharma stock forecast 2030 represents a 84595 increase from the last price of 322000002861023. Sangamo agreed to issue 100000 shares of its stock valued at just over 1 million to Ceregene shareholders as well as subsequent. EVOK stock analyst estimates including earnings and revenue EPS upgrades and downgrades.

The number of analysts covering the stock of EVOK is higher than 1307 of Healthcare stocks. The average Evoke Pharma stock price prediction forecasts a potential upside of 20303 from the current EVOK share price of 330. The more significant the discrepancy between the.

Free current stock price quotes and data for Agile Therapeutics Inc AGRX. Ad Stay Connected to the Most Critical Events of the Day with Bloomberg. Quotes Snapshot CYCC.

For Evoke Pharma stock forecast for 2032 10 year 7 predictions are offered for each month of 2032 with average Evoke Pharma stock forecast of 166 a high forecast of 1824 and a low forecast of 155. Ad 1000 Strong Buy Stocks that Double the SP. Free current stock price quotes and data for Cyclacel Pharmaceuticals Inc CYCC.

Ad Technical indicators show current momentum could push these 5 stocks even higher. Evoke Pharma Incs variance in analysts estimates is less than. Now is the time to move.

Research news charts stock market performance and earnings. EVOK IEX Real-Time Price USD. These 5 companies are set for historic price action.

See Evoke Pharma Inc. 400PM ET 805. So far the community has only identified positive things for Evoke Pharma Inc.

Find the latest analyst research for Evoke Pharma Inc. Stock information by Barrons. Losses were -854 million -3510 less than in 2020.

The current price of Evoke Pharma is the price at which Evoke Pharma is currently trading. That Evoke Pharmas share price could reach 1000 by Nov 16 2021. View real-time EVOK stock price and news along with industry-best analysis.

Research news charts stock market performance and earnings. Average price target from 1 ratings. Analyst ratings historical stock prices earnings estimates actuals.

The company plans to trade on the Nasdaq under ticker symbol EVOK. Cyclacel Pharmaceuticals Inc CYCCNASDAQ. Evoke Pharmas current and average target prices are 305 and 1000 respectively.

Agile Therapeutics Inc NASDAQ Price. Evoke Pharma EVOK Quote Overview More Research Evoke Pharma EVOK Price Target Stock Forecast. Set Alert Options Streaming Charts.

Stock Price Forecast According to 8 stock analysts the average 12-month stock price forecast for EVOK stock is 7956 which predicts an increase of 27722. EVOK updated stock price target summary.

Evoke Pharma Inc Evok Stock Price Quote News Stock Analysis